Loading stock data…
Opko Health, Inc. (OPK)
$1.51-0.02 (-1.31%)
Market ClosedLast close Jun 29
OPKO Health, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
OPKO Health, Inc. in the Healthcare sector is trading at $1.51 with a market capitalization of $1.1B. Wall Street consensus targets $4.38 (4 analysts), implying a +189.7% move over the next 12 months. The stock is currently near its 52-week high of $1.61, remaining 15.3% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 65/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +189.7% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $124.20M↓ | $148.45M↓ | $151.67M↓ | $156.81M↑ | $149.95M |
| Gross Profit | $45.76M↓ | $64.03M↑ | $49.89M↑ | $49.40M↑ | $42.62M |
| Operating Income | -$51.02M↓ | -$38.32M↑ | -$53.52M↑ | -$59.98M↑ | -$67.17M |
| Net Income | -$54.85M↓ | -$31.26M↓ | $21.63M↑ | -$148.44M↓ | -$67.61M |
Peer Comparison
JNJUNHPFE
Fundamentals
OPKO Health, Inc. operates as a healthcare company, in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company operates in two segments, Pharmaceutical and Diagnostics. The Pharmaceutical segment develops MDX2001, a...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.10B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.41
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-17.68%
Volume
Today's trading volume
4.77M
Recent News
Discover 3 Promising Penny Stocks With Market Caps Over $20M
Over the last 7 days, the U.S. market has dropped by 2.7%, yet it has risen by 23% over the past year, with earnings forecasted to grow annually by 17%. For investors interested in smaller or newer companies, penny stocks — despite being an older term — remain relevant as they can offer surprising value and growth potential when backed by strong financials. This article highlights several penny stocks that stand out for their financial strength, presenting opportunities for those seeking...
Assessing OPKO Health (OPK) Valuation After Expanded Nicoya RAYALDEE Partnership In Greater China
OPKO Health (OPK) is back in focus after amending its agreement with Nicoya Therapeutics, securing a 15% equity stake as the two companies expand their collaboration around RAYALDEE in Greater China. See our latest analysis for OPKO Health. The amended Nicoya agreement follows a strong 30 day share price return of 26.32% and a 90 day share price return of 19.01%. However, the 5 year total shareholder return is down 61.29%, so recent momentum contrasts with a weaker longer term record. If you...
How Investors May Respond To OPKO Health (OPK) Boosting Its Nicoya Stake And RAYALDEE Milestones
In early June 2026, OPKO Health reported amending its agreement with Nicoya Therapeutics, gaining a 15% equity stake while maintaining eligibility for up to US$115.0 million in potential milestone payments tied to the commercialization of RAYALDEE for chronic kidney disease patients in Greater China and related territories. This deeper partnership not only expands OPKO’s economic interest in RAYALDEE but also tightens its alignment with Nicoya ahead of planned 2027 regulatory filings across...
OPKO Health (OPK) Amends Partnership With Nicoya Therapeutics to Gain Equity Stake
OPKO Health Inc. (NASDAQ:OPK) is one of the most promising penny stocks according to Wall Street analysts. On April 30, OPKO Health amended its agreement with Nicoya Therapeutics to grant OPKO a 15% equity interest in the firm, deepening its partnership to commercialize RAYALDEE in Greater China. While the equity stake modifies the royalty and […]
OPKO Health (OPK) Up 17.1% Since Last Earnings Report: Can It Continue?
OPKO Health (OPK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.